TSNO Logo

2025年台灣神經腫瘤學學會暨顱底外科醫學會國際研討會

2025 Taiwan Society for Neuro-Oncology & Skull Base Surgery International Symposium

2025 Taiwan Society for Neuro-Oncology & Skull Base Surgery International Symposium

Recurrent Brain Tumors: Innovation and Breakthroughs

September 20-21, 2025 | Chang Gung International Convention Center, Linkou

00
Days
00
Hours
00
Minutes
00
Seconds

Conference Program

Discover the conference theme and complete schedule

Speakers

International renowned experts to be announced

Call for Papers

Abstract submission and important dates

Conference Program

Conference Theme

This conference focuses on "Recurrent Brain Tumors: Innovation and Breakthroughs," addressing treatment challenges, latest research developments, diagnostic technology innovations, and therapeutic strategy breakthroughs, with special attention to multimodal treatment and precision medicine applications.

Conference Highlights

  • International expert keynotes on recurrent brain tumor treatment trends
  • Clinical research and basic science advances in recurrent brain tumors
  • Multidisciplinary integrated treatment strategies and case discussions
  • Young researcher paper competition on brain tumors
  • Quality of life and supportive care for recurrent brain tumor patients

Conference Schedule

Coming Soon

Welcome Messages

Dr. Sanford PC Hsu

Dr. Sanford PC Hsu

President, Taiwan Society for Neuro-Oncology
Taipei Veterans General Hospital

Dear Colleagues and Friends,

On behalf of the Taiwan Society for Neuro-Oncology, it is my great pleasure to welcome you to the 2025 Taiwan Neuro-Oncology & Skull Base Society International Symposium. This year's theme, "Recurrent Brain Tumors: Innovation and Breakthroughs," addresses one of the most challenging aspects of our field.

The management of recurrent brain tumors requires multidisciplinary collaboration and innovative approaches. In recent years, we have witnessed remarkable progress in molecular diagnostics, targeted therapies, and surgical techniques. This conference will showcase these advancements through keynote lectures, expert panels, and interactive workshops.

I particularly encourage young researchers and clinicians to participate actively in our Young Investigator Forum. Your fresh perspectives and innovative ideas are crucial for advancing our field.

I look forward to welcoming you to this exciting scientific exchange.

Dr. Sanford PC Hsu
Dr. Chi-Cheng Chuang

Dr. Chi-Cheng Chuang

President, Taiwan Society for Skull Base Surgery
Chang Gung Memorial Hospital, Linkou

Dear Esteemed Colleagues,

As President of the Taiwan Society for Skull Base Surgery and on behalf of our local organizing committee at Chang Gung Memorial Hospital, I am honored to co-host this important international symposium focused on recurrent brain tumors.

Skull base tumors present unique challenges when they recur, often requiring specialized surgical approaches and multidisciplinary management. This conference will highlight cutting-edge techniques in skull base surgery, including endoscopic approaches, intraoperative imaging, and nerve preservation strategies.

Chang Gung Memorial Hospital has been at the forefront of skull base surgery in Asia, and we are proud to share our experience through live surgical demonstrations and case discussions during the conference.

We look forward to welcoming you to our institution and to fruitful scientific exchanges.

Dr. Chi-Cheng Chuang
Dr. Peng-Wei Hsu

Dr. Peng-Wei Hsu

Conference President
Chang Gung Memorial Hospital, Linkou

Dear Participants,

As Conference President, it is my privilege to welcome you to this important gathering of neuro-oncology and skull base surgery experts from around the world. The theme of recurrent brain tumors is particularly timely, as we face increasing challenges in managing these complex cases.

This conference has been carefully designed to provide practical, clinically relevant knowledge that you can apply immediately in your practice. From molecular diagnostics to innovative surgical techniques and novel therapeutic approaches, we have assembled an outstanding program that addresses the full spectrum of recurrent brain tumor management.

I encourage you to take full advantage of the networking opportunities during the conference. Some of the most valuable insights often come from informal discussions with colleagues facing similar challenges.

We are committed to making this conference a memorable and productive experience for all participants.

Dr. Peng-Wei Hsu
Dr. Pin-Yuan Chen

Dr. Pin-Yuan Chen

Conference Secretary General
Chang Gung Memorial Hospital, Keelong

Dear Friends and Colleagues,

As Secretary General of this conference, I am delighted to welcome you to what promises to be an outstanding scientific meeting. Our organizing committee has worked diligently to create a program that balances cutting-edge science with practical clinical applications.

The abstract submission process was highly competitive this year, reflecting the growing interest in recurrent brain tumor research. I congratulate all authors whose work was accepted for presentation and encourage all participants to engage actively with the presenters.

For our international guests, we have arranged special social events to introduce you to Taiwanese culture and cuisine. These informal gatherings often lead to lasting professional collaborations and friendships.

Please don't hesitate to approach any member of our organizing committee if you need assistance during the conference. We are here to ensure your experience is both productive and enjoyable.

Dr. Pin-Yuan Chen

Speakers

Coming Soon

Our exciting lineup of speakers will be announced soon!

We are inviting top neuro-oncology and skull base surgery experts from the United States, Europe, and Asia, including:

  • • International authorities in recurrent brain tumor treatment
  • • Molecular diagnostics and precision medicine experts
  • • Neurosurgical innovation specialists
  • • Radiation therapy and immunotherapy experts
  • • Skull base surgery pioneers

Call for Papers

Important Dates

Abstract Submission System Opens
May 25, 2025
Abstract Submission Deadline
July 31, 2025
Notification of Abstract Acceptance
August 15, 2025
Deadline for E-poster Submission
September 5, 2025

Abstract Categories

Basic Science: Neuro-Oncology, Molecular Biology, Genetics

Neurosurgical Techniques

Pediatric Brain Tumors

Radiation Oncology

Medical Oncology and Chemotherapy

Neuroimaging and Diagnostics

Neuropathology

Supportive Care and Palliative Medicine

Immunotherapy and Targeted Therapies

Clinical Trials and Translational Research

Recurrent Tumor Management

Skull Base Surgery

Others

General Guidelines

  • All abstracts must be submitted online via the official TSNO 2025 submission link and written in English.
  • Encore abstracts (previously presented at other conferences or published in journals) are permitted but must include details of the prior presentation or publication.
  • There is no limit on the number of abstracts that can be submitted per account.
  • The same abstract cannot be submitted under different abstract categories.
  • All correspondence will be sent to the person submitting the abstract (presenting author).

Abstract Requirements

Abstract Authors

  • • The submitter is considered the first author, presenting author, and corresponding author by default.
  • • Full registration payment is required for presenting authors to be entitled to present.
  • • The number of co-authors is limited to a maximum of 10.

Abstract Title

  • • The title must not exceed 50 words, excluding spaces.
  • • Author and institution information must not appear in the title. If either an author's name or institution information appears, the abstract will be disqualified.

Presentation Type

Submitters may choose their preferred presentation type (Oral or E-Poster). However, the TSNO 2025 Scientific Committee will make the final decision after review.

Research Types

There are two research types:

  • Basic Research: The abstract body must include four sections: Objectives, Materials and Methods, Results, and Conclusion.
  • Case Report: The abstract body must include three sections: Introduction, Case Description, and Discussion/Conclusion.

Abstract Body/Text

  • • The abstract body must not exceed 400 words, excluding spaces.
  • • Images and tables must not be pasted in the abstract text. Each abstract may include ONE image (JPG or PNG format, max. 5MB), which should be uploaded separately into the submission system. This image can be a figure or a table.

Presentation Formats

Oral Presentation

Selected abstracts will be invited for oral presentation during the conference. Presenters must also submit an e-poster.

E-Poster Presentation

Accepted abstracts will be displayed as e-posters on the TSNO 2025 official website.

E-Poster Submission Requirements

  • • Required for all accepted abstracts (including oral presentations)
  • • Format: Use the official TSNO 2025 E-Poster Template (available on the website after August 15, 2025)
  • • Export as PDF for upload
  • • Deadline: September 5, 2025, 23:59 (Taiwan Time)
  • • Note: Printed posters are not accepted

Additional Notes

  • Ethical Considerations: Authors must ensure compliance with ethical standards, including obtaining approval from relevant institutional review boards for studies involving human subjects.
  • Conflict of Interest: Disclose any potential conflicts of interest in the submission form.
  • Plagiarism: TSNO 2025 has a strict policy against plagiarism. Submissions found to violate this policy will be rejected.
Submit Your Abstract

Visit the official submission portal to submit your abstract

Venue

Chang Gung International Convention Center, Linkou

Address: No. 5, Fuxing St., Guishan Dist., Taoyuan City (Next to Chang Gung Transit Station)

Transportation

  • Airport MRT: A8 Chang Gung Memorial Hospital Station, 3-minute walk to Chang Gung Transit Station
  • Bus routes: 936, 937, 945, 946, 1211, 1212 to Chang Gung Transit Station
  • Parking: Convention Center underground parking (paid), Chang Gung Transit Station parking

Recommended Accommodation

  • Fullon Hotel (5-minute walk)

R5 教育訓練

R5 教育訓練口頭報告公告

本年度 R5 教育訓練,將由各院R5進行腦瘤相關研究之口頭發表。每人報告時間10–15分鐘,報告後開放討論與講評,由在場指導醫師共同給予評分,並於課程結束後核發參與證明。

建議報告主題範圍但不限定

請擇一方向進行深入探討,可為研究回顧或實際病例分析(評分會有差異):

1 Meningioma
2 Glioma
3 Metastatic brain tumor
4 Schwannoma (Acoustic / Trigeminal)
5 Pituitary tumor

時程規劃

7/01(二)前

請繳交報告題目或主題大方向

8/22(五)前

需繳交 Abstract(400 字以內),比照年會投稿規範。

重要提醒

請依時繳交,並可提前與指導醫師討論方向。

聯絡資訊

如有任何問題,請聯繫學會秘書

Sponsors

Sponsor 1 Sponsor 2 Sponsor 3